BioSyent Schedules Q1 2020 Earnings Release For May 28, 2020
21 mai 2020 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 21, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2020 on...
FeraMAX® Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Fifth Consecutive Year
01 mai 2020 09h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 01, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that for the fifth consecutive year, FeraMAX® has been named the #1...
BIOSYENT ANNOUNCES GRANT OF RESTRICTED SHARE UNITS
31 mars 2020 19h41 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 31, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved today a grant of 129,125...
BioSyent Releases Results for Fourth Quarter and Full Year 2019
18 mars 2020 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 18, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and twelve months ended December...
BIOSYENT SCHEDULES Q4 AND FULL YEAR 2019 EARNINGS RELEASE FOR MARCH 18, 2020
11 mars 2020 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 11, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and twelve months ended...
BioSyent Announces Adoption of Restricted Share Unit Plan
06 mars 2020 17h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 06, 2020 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a Restricted Share Unit Plan...
BioSyent Announces Renewal of Normal Course Issuer Bid
11 déc. 2019 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Dec. 11, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the...
BioSyent Signs Exclusive Agreement for Pain Management Products
25 nov. 2019 17h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive License...
BioSyent Releases Results for Third Quarter and First Nine Months of 2019
20 nov. 2019 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 20, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September...
BioSyent Schedules Q3 and YTD 2019 Earnings Release for November 20, 2019
12 nov. 2019 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...